Abstract: |
Zbtb7a has previously been described as a powerful proto-oncogene. Here we unexpectedly demonstrate that Zbtb7a has a critical oncosuppressive role in the prostate. Prostate-specific inactivation of Zbtb7a leads to a marked acceleration of Pten loss-driven prostate tumorigenesis through bypass of Pten loss-induced cellular senescence (PICS). We show that ZBTB7A physically interacts with SOX9 and functionally antagonizes its transcriptional activity on key target genes such as MIA, which is involved in tumor cell invasion, and H19, a long noncoding RNA precursor for an RB-targeting microRNA. Inactivation of Zbtb7a in vivo leads to Rb downregulation, PICS bypass and invasive prostate cancer. Notably, we found that ZBTB7A is genetically lost, as well as downregulated at both the mRNA and protein levels, in a subset of human advanced prostate cancers. Thus, we identify ZBTB7A as a context-dependent cancer gene that can act as an oncogene in some contexts but also has oncosuppressive-like activity in PTEN-null tumors. © 2013 Nature America, Inc. All rights reserved. |
Keywords: |
signal transduction; controlled study; dna-binding proteins; nonhuman; animal cell; mouse; animals; mice; animal tissue; proto oncogene; microrna; models, biological; animal experiment; animal model; down-regulation; cell line, tumor; mice, inbred c57bl; carcinogenesis; mice, transgenic; transcription factors; cell transformation, neoplastic; prostate cancer; prostatic neoplasms; cancer inhibition; gene expression regulation, neoplastic; messenger rna; nucleotide sequence; phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase; pten phosphohydrolase; tumor cell; down regulation; neoplasm invasiveness; senescence; tumor gene; cell aging; cell invasion; genes, tumor suppressor; transcription factor sox9; sox9 transcription factor; tumor invasion; zbtb7a gene
|